Hip Replacement Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product Type (Primary Hip Reconstruction Devices, Partial Hip Reconstruction Devices, Revision Hip Reconstruction Devices, Hip Resurfacing Devices), By End User (Hospitals, Ambulatory Care Centers, Orthopedics Clinics, Others), By Region, & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 6.11 Billion
CAGR (2026-2031)	4.0%
Fastest Growing Segment	Primary Hip Reconstruction Devices
Largest Market	North America
Market Size (2031)	USD 7.73 Billion

Market Overview

The Global Hip Replacement Devices Market is projected to grow from USD 6.11 Billion in 2025 to USD 7.73 Billion by 2031 at a 4.0% CAGR. Hip replacement devices are specialized medical implants engineered to restore function and alleviate pain in hip joints severely damaged by conditions such as osteoarthritis, rheumatoid arthritis, or acute trauma. The market for these devices is primarily driven by a globally aging population, which inherently faces a higher incidence of degenerative joint diseases, alongside the increasing prevalence of osteoarthritis worldwide. Further impetus comes from continuous advancements in materials and surgical techniques, leading to improved patient outcomes and device longevity. According to the American Academy of Orthopaedic Surgeons American Joint Replacement Registry, its 2025 Annual Report analyzed over 4.4 million total hip and knee arthroplasty procedures performed in the United States, utilizing data collected through 2024.

A significant challenge impeding market expansion globally remains the high cost associated with both the hip replacement devices and the surgical procedures. These substantial expenses can restrict patient access, particularly in regions with less developed healthcare infrastructures or limited reimbursement policies, thereby limiting the overall market penetration.

Key Market Drivers

Increasing geriatric population significantly influences the Global Hip Replacement Devices Market by expanding the demographic most susceptible to age-related joint degradation. As individuals live longer, the cumulative wear and tear on joints, particularly the hips, necessitates restorative interventions. This demographic shift directly translates into a higher volume of potential patients for hip replacement surgeries. According to the United Nations Department of Economic and Social Affairs, Population Division, in their "World Population Prospects 2024," global life expectancy at birth reached 73.3 years in 2024, demonstrating an increasingly aging global populace. The extended lifespan contributes to an elevated need for solutions that maintain mobility and quality of life in older adults.

The rising prevalence of osteoarthritis and other degenerative joint diseases represents a critical driver for the market, as these conditions are primary indications for hip replacement. Factors such as obesity and sedentary lifestyles contribute to the accelerated onset and progression of these debilitating diseases. The growing number of affected individuals directly fuels demand for effective treatment options, including hip arthroplasty. According to a study published in "Global, regional, and national burden of osteoarthritis among middle-aged and older adults" in December 2025, an estimated 453.56 million older individuals were living with osteoarthritis globally in 2021. This substantial patient pool underscores the ongoing need for advanced hip replacement technologies. According to Stryker's Q4 2025 earnings report, its full-year orthopedic net sales for 2025 reached $9.5 billion.

Download Free Sample Report

Key Market Challenges

The elevated cost associated with both hip replacement devices and the intricate surgical procedures poses a significant impediment to the global market's expansion. These substantial expenses directly restrict patient access, particularly in regions with less developed healthcare infrastructures or those with restrictive reimbursement policies, thereby limiting the overall market penetration. The financial burden extends beyond the initial device acquisition, encompassing the entire surgical intervention and subsequent rehabilitation. This pervasive economic barrier can deter eligible patients from pursuing necessary surgery, even when experiencing severe pain and functional impairment from conditions like osteoarthritis.

According to a 2023 survey by the American Medical Association, 78% of physicians indicated that delays caused by prior authorization, a prevalent cost-controlling measure, led their patients to forgo essential medical care, including procedures pertinent to hip arthroplasty. Such widespread abandonment of care, driven by financial complexities, directly reduces the potential volume of procedures performed, consequently stifling growth within the global hip replacement devices market by reducing the addressable patient population.

Key Market Trends

The integration of robotic and computer-assisted surgery stands as a significant trend reshaping the global hip replacement devices market. These advanced systems provide surgeons with enhanced precision and control, improving upon traditional manual techniques. By enabling meticulous pre-operative planning based on patient anatomy and offering real-time guidance during surgery, such technologies aim to optimize implant positioning and recovery. For instance, according to Stryker's internal data on file, over 2 million Mako procedures have been performed globally through 2025, indicating widespread adoption of these tools across orthopedic interventions. This technological shift is driven by the potential for more consistent outcomes and reduced complications.

Another prominent trend is the rising demand for patient-specific and 3D-printed implants. This approach facilitates the creation of customized devices that precisely match an individual's unique anatomical structure, addressing variations that standard implants may not accommodate. Patient-specific implants can lead to a more accurate fit, potentially improving joint mechanics, reducing wear, and enhancing long-term implant longevity. The ability to design and produce implants tailored to specific patient needs supports more predictable surgical results, especially in complex cases. According to Materialise's Fourth Quarter and Full Year 2025 Results, published February 18, 2026, its personalized solutions were used to treat over 17,000 patients in 2025 alone. This trend emphasizes a move towards personalized medicine within hip arthroplasty, leveraging additive manufacturing for superior functional outcomes.

Segmental Insights

The Primary Hip Reconstruction Devices segment is experiencing significant and rapid growth within the Global Hip Replacement Devices Market, primarily driven by the increasing worldwide prevalence of degenerative joint diseases such as osteoarthritis and rheumatoid arthritis, which frequently necessitate initial surgical intervention. This expansion is further fueled by a growing geriatric population, a demographic particularly susceptible to hip ailments and fractures, thereby increasing the demand for primary hip replacement procedures. Additionally, continuous advancements in implant materials, design innovations like highly cross-linked polyethylene liners and advanced ceramic heads, and the adoption of minimally invasive surgical techniques, enhance patient outcomes and implant longevity, contributing to the segment's robust market trajectory. Regulatory oversight from bodies such as the Food and Drug Administration ensures device safety and effectiveness, fostering clinical confidence in these essential medical solutions.

Regional Insights

North America emerges as the leading region in the global hip replacement devices market, primarily due to its advanced healthcare infrastructure and significant healthcare expenditure. The region experiences a high prevalence of orthopedic conditions such as osteoarthritis and hip fractures, driven by an aging population, which consistently fuels the demand for hip replacement procedures. Favorable health reimbursement policies, including those provided by Medicare, further enhance patient access to these critical interventions. Moreover, North America benefits from the rapid adoption of technologically advanced implants and innovative surgical techniques, including robotic-assisted procedures. The stringent regulatory oversight from bodies like the U.S. Food and Drug Administration also ensures device quality and market confidence.

Recent Developments

• In March 2026, Maxx Orthopedics, Inc. announced the launch of its Libertas® Keystone™ Hip System, an expansion of its existing Libertas® Hip Portfolio. This new product is a short, metaphyseal fit-and-fill hip stem engineered to advance contemporary direct anterior approach hip arthroplasty. The Keystone™ Stem features a compact profile to minimize soft tissue disruption during insertion and incorporates a proprietary dual coating of Titanium Plasma Spray and Hydroxyapatite for optimal osseointegration in the proximal region. This design specifically targets reproducible outcomes and enhanced surgical efficiency within the global hip replacement devices market.
• In March 2026, the French company ImpacTell prepared to commercialize its instrumented hammer, known as the SmartHammer, which offers orthopaedic surgeons objective and reliable estimates of implant stability during hip replacement surgery. The device, developed through the EU-funded Impactor project, integrates an AI-driven decision support system into a conventional surgical hammer equipped with sensors. The SmartHammer is designed to measure the resonance frequency of the bone-implant system, moving beyond traditional empirical methods. This innovation aims to reduce the risk of aseptic loosening and peroperative fractures in hip replacement procedures.
• In October 2025, Zimmer Biomet Holdings, Inc. received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its iodine-treated total hip replacement system. This marks the first time such a designation has been granted for a product from the company. The innovative technology integrates a controlled-release iodine surface treatment into the iTaperloc® Complete and iG7™ Hip System, designed to mitigate challenges associated with periprosthetic joint infections in patients at higher risk. This system had previously secured approval from the Japan Pharmaceutical and Medical Devices Agency in September 2025, becoming the world’s first approved orthopedic implant featuring Iodine Technology.
• In October 2025, a new ceramic hip resurfacing implant, the H1, was introduced at Cleveland Clinic London. Developed at Imperial College London, this implant received approval from the UK’s Medicines and Healthcare Products Regulatory Agency in 2025. This breakthrough in hip replacement devices aims to broaden hip resurfacing as a viable option for more patients, particularly those with smaller bone structures, including many women, who had limited or no suitable resurfacing choices for a decade. The H1 ceramic implant is designed to address issues of pain and soft tissue impingement often associated with previous metal-on-metal hip resurfacing components.

Key Market Players

• Johnson & Johnson
• B. Braun Melsungen AG
• Stryker Corporation
• Zimmer Biomet Holdings Inc
• Corin Group
• Waldemar LINK GmbH & Co. KG
• MicroPort Scientific Corporation
• Exactech Inc.
• Conformis Inc.
• OMNIlife Science Inc

By Product Type	By End User	By Region
Primary Hip Reconstruction Devices Partial Hip Reconstruction Devices Revision Hip Reconstruction Devices Hip Resurfacing Devices	Hospitals Ambulatory Care Centers Orthopedics Clinics Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Hip Replacement Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Hip Replacement Devices Market , By Product Type:

• Primary Hip Reconstruction Devices
• Partial Hip Reconstruction Devices
• Revision Hip Reconstruction Devices
• Hip Resurfacing Devices

• Hip Replacement Devices Market , By End User:

• Hospitals
• Ambulatory Care Centers
• Orthopedics Clinics
• Others

• Hip Replacement Devices Market , By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE